SM
BIIB icon

Sabby Management’s Biogen BIIB Stock Holding History

Sabby Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,518
Closed -$42.5M – 168
2021
Q1 		$42.5M Sell
1,518
-1,244
-45% -$335K 8.26% 3
2020
Q4 		$67.6M Sell
2,762
-592
-18% -$153K 12.96% 1
2020
Q3 		$95.1M Buy
3,354
+1,550
+86% +$432K 14.2% 1
2020
Q2 		$48.3M Buy
+1,804
New +$542K 9.69% 2
2020
Q1 		– Sell
-28
Closed -$831K – 91
2019
Q4 		$831K Buy
+28
New +$7.77K 0.23% 22
2019
Q3 		– Sell
-410
Closed -$9.59M – 96
2019
Q2 		$9.59M Sell
410
-1,893
-82% -$437K 12.06% 2
2019
Q1 		$54.4M Buy
2,303
+2,273
+7,577% +$716K 26.15% 1
2018
Q4 		$903K Buy
+30
New +$9.57K 0.2% 38
2018
Q3 		– Sell
-30
Closed -$871K – 130
2018
Q2 		$871K Hold
30
– – 0.13% 64
2018
Q1 		$821K Buy
+30
New +$9.31K 0.1% 77
2017
Q1 		– Sell
-115
Closed -$3.26M – 269
2016
Q4 		$3.26M Sell
115
-552
-83% -$164K 0.19% 74
2016
Q3 		$20.9M Sell
667
-1,199
-64% -$355K 0.78% 27
2016
Q2 		$45.1M Sell
1,866
-4,797
-72% -$1.26M 2.35% 9
2016
Q1 		$173M Buy
6,663
+3,226
+94% +$852K 8.68% 4
2015
Q4 		$105M Buy
3,437
+347
+11% +$99.7K 5.79% 4
2015
Q3 		$90.2M Sell
3,090
-1,255
-29% -$414K 3.71% 5
2015
Q2 		$176M Buy
4,345
+1,243
+40% +$499K 6.4% 4
2015
Q1 		$131M Sell
3,102
-1,478
-32% -$583K 5.45% 3
2014
Q4 		$155K Buy
4,580
+400
+10% +$129K 4.91% 4
2014
Q3 		$138K Buy
4,180
+692
+20% +$228K 5.31% 5
2014
Q2 		$110M Buy
3,488
+1,413
+68% +$425K 4.72% 3
2014
Q1 		$63.5M Buy
2,075
+1,172
+130% +$372K 3.56% 7
2013
Q4 		$25.3M Buy
903
+29
+3% +$7.5K 1.61% 14
2013
Q3 		$21M Buy
+874
New +$196K 1.37% 20

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management's BIIB Position: Q3 2021 in Review

Sabby Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 4,000 shares — an estimated $1.39M sold.

Sabby Management first reported a position in BIIB in Q3 2015 and held it in 13 quarters. The position peaked at $50.1M in Q1 2018. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Sabby Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Sabby Management sold 4,000 Biogen shares in Q3 2021, an estimated $1.39M.
  • Sabby Management first reported a position in Biogen in Q3 2015 and held it in 13 quarters.
  • Sabby Management's Biogen position peaked at $50.1M in Q1 2018.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.